Beyond the Headlines: What Pfizer’s $495M Sciwind Deal Really Signals for the GLP-1 Supply Chain
When Pfizer announced it would pay up to $495 million to commercialize Sciwind Biosciences’ GLP-1 agonist ecnoglutide in China, most […]
When Pfizer announced it would pay up to $495 million to commercialize Sciwind Biosciences’ GLP-1 agonist ecnoglutide in China, most […]
Although China’s polypeptide cosmetics market started relatively late, its unique market dynamism and rapidly iterating local innovations have made it
As polypeptide drugs, represented by GLP-1, expand their applications across numerous chronic diseases—such as diabetes, weight management, chronic kidney disease,
I. Why Polypeptides Must Be Discussed Today Over the past 12 months, the hottest pharmaceutical keyword in global capital markets
Polypeptides are compounds formed by multiple amino acids linked through peptide bonds, typically consisting of 10 to 100 amino acids